• Therapeutic Cataract & Refractive
  • Lens Technology
  • Glasses
  • Ptosis
  • Comprehensive Eye Exams
  • AMD
  • COVID-19
  • DME
  • Ocular Surface Disease
  • Optic Relief
  • Geographic Atrophy
  • Cornea
  • Conjunctivitis
  • Myopia
  • Presbyopia
  • Allergy
  • Nutrition
  • Pediatrics
  • Retina
  • Cataract
  • Contact Lenses
  • Lid and Lash
  • Dry Eye
  • Glaucoma
  • Refractive Surgery
  • Comanagement
  • Blepharitis
  • OCT
  • Patient Care
  • Diabetic Eye Disease
  • Technology

Vistakon introduces 1-Day Acuvue TruEye CLs


Vistakon Division of Johnson & Johnson Vision Care Inc. has announced the U.S. introduction of 1-Day Acuvue TruEye (narafilcon A) contact lenses.


Jacksonville, FL-Vistakon Division of Johnson & Johnson Vision Care Inc. has announced the U.S. introduction of 1-Day Acuvue TruEye (narafilcon A) contact lenses (CLs). 1-Day Acuvue TruEye is now available at some U.S. eyecare professionals’ (ECP’s) offices, with distribution expected to grow in the coming months.

The lens features Hydraclear 1 Technology, which attracts tear film to help maintain the natural ocular environment for all-day comfort, High O2 Consumption, allowing 100 percent corneal oxygen consumption at all points across minus and plus powers, and Class-1 UV-blocking, offering patients the highest level of UV protection in a contact lens, blocking approximately 96 percent of UV-A rays and greater than 99 percent of UV-B rays that reach the lens.

1-Day Acuvue TruEye (narafilcon A) will gradually replace 1-Day Acuvue TruEye (narafilcon B), which was launched in the U.S. in 2010. 

Dave Brown, Vistakon president, said: “Our aim is to quickly transition to 1-Day Acuvue TruEye (narafilcon A), and we will provide doctors with a number of tools to help smooth the conversion process for ECPs and patients. We are confident that 1-Day Acuvue TruEye (narafilcon A) will help doctors make more patients happy, and drive additional patient referrals-the key to practice growth.”

Related Videos
Raman Bhakhri, OD, FAAO, overviews his talk on medications' potential side effects on the retina with Optometry Times
Jacobi Cleaver, OD, FAAO
Jade Coats, OD, overviews a lecture on ocular pain and patient care
Jade Coats, OD, outlines two poster presentations she gave on a novel lipid-containing eye drop at the AOA Optometry's Meeting
Adam Alexander, OD, chats with Optometry Times about his AOA e-poster presentation on Miebo
Lorraine Provencher, MD, presenting slides
Megan Cavet, PhD
Nazlee Zebardast, MD, MSc, overviews her ARVO 2024 presentations on glaucoma and polygenic risk scores
© 2024 MJH Life Sciences

All rights reserved.